Abstract

Induction of DNA double-strand breaks (DSBs) in ribosomal DNA (rDNA) repeats is associated with ATM-dependent repression of ribosomal RNA synthesis and large-scale reorganization of nucleolar architecture, but the signaling events that regulate these responses are largely elusive. Here we show that the nucleolar response to rDNA breaks is dependent on both ATM and ATR activity. We further demonstrate that ATM- and NBS1-dependent recruitment of TOPBP1 in the nucleoli is required for inhibition of ribosomal RNA synthesis and nucleolar segregation in response to rDNA breaks. Mechanistically, TOPBP1 recruitment is mediated by phosphorylation-dependent interactions between three of its BRCT domains and conserved phosphorylated Ser/Thr residues at the C-terminus of the nucleolar phosphoprotein Treacle. Our data thus reveal an important cooperation between TOPBP1 and Treacle in the signaling cascade that triggers transcriptional inhibition and nucleolar segregation in response to rDNA breaks.

DNA double-strand breaks in ribosomal DNA repeats is associated with repression of ribosomal RNA synthesis. Here the authors reveal a cooperation between TOPBP1 and Treacle in the signaling cascade that triggers transcriptional inhibition and nucleolar segregation in response to rDNA breaks.

Details

Title
Treacle controls the nucleolar response to rDNA breaks via TOPBP1 recruitment and ATR activation
Author
Mooser Clémence 1 ; Ioanna-Eleni, Symeonidou 1 ; Pia-Amata, Leimbacher 1 ; Ribeiro, Alison 1 ; Shorrocks, Ann-Marie K 2 ; Jungmichel Stephanie 3 ; Larsen, Sara C 3   VIAFID ORCID Logo  ; Knechtle Katja 1 ; Jasrotia Arti 1 ; Zurbriggen, Diana 1 ; Jeanrenaud Alain 1 ; Leikauf Colin 1   VIAFID ORCID Logo  ; Fink, Daniel 1 ; Nielsen, Michael L 3   VIAFID ORCID Logo  ; Blackford, Andrew N 4   VIAFID ORCID Logo  ; Stucki, Manuel 1   VIAFID ORCID Logo 

 University of Zurich, Department of Gynecology, Schlieren, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650) 
 University of Oxford, John Radcliffe Hospital, Department of Oncology, Medical Research Council Weatherall Institute of Molecular Medicine, Oxford, UK (GRID:grid.7400.3) ; University of Oxford, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 University of Copenhagen, Faculty of Health and Medical Sciences, The Novo Nordisk Foundation Center for Protein Research, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X) 
 University of Oxford, John Radcliffe Hospital, Department of Oncology, Medical Research Council Weatherall Institute of Molecular Medicine, Oxford, UK (GRID:grid.5254.6) ; University of Oxford, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2342387200
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.